Overview

The Foundation raises funds and manages University Research Chairs in support of research in lung transplantation, thoracic oncology and oesophageal diseases. It promotes the excellence of specialized teams, serving the people of Quebec. The Foundation has created partnerships with corporations, pharmaceutical companies, the community and other Foundations. The primary goal is to raise funds to create endowed University Chair positions for each section of the Division. From the outset, the projects have received unconditional support from University of Montreal and its Faculty of Medicine, as well as from Le Centre Hospitalier de l’Université de Montréal (CHUM).

The Research Chairs

Since its inception, the Division and the Foundation have been successful in creating three endowed University Chairs:

  • “THE MARCEL AND ROLANDE GOSSELIN CHAIR IN THORACIC SURGICAL ONCOLOGY” – the tenured title holder is Dr Moishe Liberman
  • THE ALFONSO MINICOZZI AND FAMILY CHAIR IN THORACIC SURGERY AND LUNG TRANSPLANTATION” – the tenured title holder is Dr Pasquale Ferraro
  • and coming soon the “RÉGIS MORISSETTE – FRANSYL – MORRISSETTE FAMILY CHAIR IN THORACIC SURGERY AND OESOPHAGEAL DISEASES”.

Objectives:

  • Promote excellence in clinical care, teaching and research in the fields of lung transplantation, oesophageal diseases and thoracic oncology
  • Ensure the recruitment and the retention of surgeons with a high level of academic expertise and to train them to become the next generation of highly-qualified clinical researchers
  • Amass permanent funding to ensure necessary support for clinical researchers
  • • Reinforce the competitiveness of the CHUM both nationally and internationally

University Chair in Thoracic Surgery and Lung Transplantation

Since its inception in 1997, the University of Montreal lung transplant program has established itself as the second largest program in Canada and among the 15 largest programs in North America. The creation of the Alfonso Minicozzi and Family Chair in Thoracic Surgery and Lung Transplantation provides not only significant support but contributes towards maintaining our objective to offer excellent care in the field of lung transplantation. The Alfonso Minicozzi and Family Chair in Thoracic Surgery and Lung Transplantation will not only ensure the growth and development of the transplant program, but will also provide researchers with the necessary support to help maintain their role as leaders in the field. Dr. Pasquale Ferraro, Professor at the University of Montreal and head of the Thoracic Surgery Department of the CHUM is the tenured title holder of this Chair.

General Objectives:

  • Ensure the survival and development of a single lung transplant program in Quebec
  • Foster and retain the recruitment of excellent resources
  • Improve access to ensure we are at the forefront of healthcare for the people of Quebec
  • Allow patients with lung disease to maintain hope and to overcome their disease
  • Create a full time tenured professorship within our Division at the University of Montreal
  • Ensure constant cash flow & funding to support research
  • Provide highly specialized training grants for young surgeons in our transplant program
  • Develop a training program for basic clinical research for incoming doctors from other universities
  • Provide material resources for basic research in molecular and cellular biology
  • Develop and participate in clinical and basic research in immunosuppression protocols to reduce the risk of rejections
  • Maintain clinical and basic research on the preservation of grafts and pulmonary edema
  • Develop research in genetic therapy
  • Develop an ex-vivo lung perfusion program

University Chair in Thoracic Surgical Oncology

Lung cancer is the number one cause of cancer-related deaths in both men and women in North America. The Thoracic Surgery Division at the CHUM has, for a long time, been the busiest thoracic surgery division in the Province of Quebec, and offers patients a full range of services for diagnosis and treatment of thoracic malignancies. The Marcel and Rolande Gosselin Chair in Thoracic Surgical Oncology helps ensure the recruitment of thoracic surgeons with expertise in oncology and highly-specialized academic training. Our Thoracic Surgical Oncology section strives to provide innovative care to patients with thoracic malignancies through the use of the most recent, minimally invasive technology. Basic science research in areas such as molecular biology, gene profiling and tumour markers, tissue banking and pharmacology is rapidly evolving. We are confident that developments in this field will one day provide physicians and surgeons with more effective and targeted therapy for patients with thoracic malignancies for potentially better long-term outcomes. The Marcel and Rolande Gosselin Chair in Thoracic Surgical Oncology will not only help support our commitment to excellence in clinical care, teaching and research, but also maintain our role as leaders in the area of thoracic malignancies. Dr. Moishe Liberman, assistant Professor at the University of Montreal and a member of the Thoracic Surgery Department at the CHUM, is the tenured title holder of this Chair.

General Objectives:

  • Create a full-time University professorship within our Division at the University of Montreal;
  • Create the proper environment necessary for the recruitment of academic thoracic surgeons with an expertise in thoracic oncology and basic research;
  • Provide steady funding for basic science research in thoracic oncology;
  • Sustain the development of the program within our Thoracic Surgery Division at the University of Montreal;
  • Help support fellowship training for newly recruited thoracic oncology surgeons.

Specific Objectives:

  • Develop a research program in molecular biology, gene profiling, tumour markers and tissue banking;
  • Develop a research program in minimally invasive endoluminal diagnosis and staging of both lung and oesophageal cancer;
  • Develop and support innovative research in minimally invasive technology assessment and development of new technologies;
  • Participate in multi-center clinical trials in thoracic cancer treatment;
  • Develop a world-renowned referral center for endoscopic thoracic interventions;
  • Support research efforts in tumour vaccines;
  • Develop research and clinical expertise in the palliative treatments for cancers of the respiratory tract;
  • Develop an intra- and extra-luminal investigative program by ultrasound.

University Chair in Oesophageal Diseases and minimally invasive surgery

The field of oesophageal diseases deals with a wide spectrum of both benign and malignant disorders. Motor disorders of the oesophagus, which present themselves through difficulty in swallowing, often have a major impact on patient quality of life. Oesophageal trauma and perforation represent an important challenge to thoracic surgeons. Reflux disease, which now affects nearly 50% of the population, is responsible for a pre-malignant condition known as Barrett’s oesophagus. In recent years, the occurrence of oesophageal cancer in industrialized countries has increased at an exponential rate, making it the cancer with the fastest rising incidence. Thoracic surgery is also undergoing an important evolution with the advent of Minimally Invasive Surgery (MIS). Carrying out complex thoracic procedures using a minimally invasive approach is rapidly becoming the mainstay of therapy for a number of oesophageal disorders. Reduced hospital stays, shorter time to recovery and less pain and discomfort with equivalent results are being reported. The Thoracic Surgery Division at the CHUM has established itself over the years as the pivotal referral center for patients with oesophageal diseases from all regions of Quebec. Our comprehensive approach to patient care includes a complete functional assessment of the oesophagus, as well as a wide array of diagnostic and therapeutic procedures. New and exciting techniques are being developed to assess physiology, perform diagnostic endoscopic procedures, to improve the staging of cancers and to perform complex surgical procedures in the operating room. Presently, the oesophageal disease section of our Division relies on a single dedicated thoracic surgeon, and thus recruiting a second highly-trained academic surgeon has become a priority. We believe the creation of a University Chair professorship is essential to help recruit new surgeons and to support our commitment to excellence. In an effort to ensure the growth and development of our section of oesophageal diseases, our Division and Foundation have turned their attention to creating the Régis Morissette – Fransyl – Morrissette Family Chair in Thoracic Surgery and Oesophageal Diseases. This University Chair will provide surgeons with the necessary support to help maintain their role as leaders in the area of oesophageal diseases.

General Objectives:

  • Create a full time position for a University chair professorship for oesophageal diseases in our Division at the University of Montreal;
  • Provide steady funding for clinical and basic science research in the field of oesophageal diseases and MISRecruit new surgeons whose specialization lends to expertise in the evaluation and treatment of oesophageal diseases
  • Create a welcoming environment that helps promote the retention of professors oriented towards excellence in clinical care, teaching and research
  • Develop new therapeutic approaches towards the treatment of oesophageal diseases
  • Help support fellowship training for newly recruited oesophageal surgeons
  • Create a highly-specialized center dedicated to the diagnosis and treatment of oesophageal diseases

Specific Objectives:

  • Develop the area of genetics through the evaluation and treatment of benign and malignant oesophageal diseases
  • Support prospective clinical research studies in patients with Barrett’s oesophagus
  • Support a prospective randomized trial on massive hiatal hernias
  • Minimally invasive approach versus open thoracotomy
  • Support a prospective evaluation of oesophageal cancer treatment
  • Support basic science research in oesophageal physiology
  • Support the development of high resolution manometry, electromyography and endoscopic ultrasound in the assessment of motor dysfunction
  • Create a comprehensive database for the assessment, treatment and follow-up of oesophageal diseases

MISSION & HISTORY
FROM THE PRESIDENT
BOARD OF DIRECTORS
CETOC
EX VIVO PROGRAM
MATERIAL AND PUBLICATIONS